Is Angi, Inc. overvalued or undervalued?

As of 28 November 2025, the valuation grade for Angi, Inc. has moved from fair to expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, which suggests that the stock is trading at a premium compared to its earnings and book value. In comparison to peers, Angi, Inc. has a P/E ratio of 14.77, while GoodRx Holdings, Inc. stands out with a much higher P/E of 31.76, indicating a significant valuation disparity. Additionally, eGain Corp. shows a P/E of 6.67, further emphasizing Angi's expensive valuation relative to its peers. Although specific return data is not available, the lack of recent performance metrics against the S&P 500 reinforces the notion that Angi, Inc. may not be a compelling investment at its current valuation.